Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/E ratio high or low?
The P/E ratio of 19.43 is 94% below its 1-year average of 352.62, near the low end of its 1-year range (19.43–654.42).
As of 2026-10-06T14:47:40.992Z.
Calculation as of: 2026-10-06T14:47:40.992Z.
Quote observation: 2026-10-06T14:45:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 295890ca45b9fb7c845dc9b7cfc12ce3e82df22f7cd737cbd4420fef5fb5231a
PE Ratio (19.43) = Close Price ($26.60) / Diluted TTM EPS ($1.37)
PE RATIO
19.43
PE RATIO AVG TTM
N/A
PE RATIO AVG 3Y
N/A
PE RATIO AVG 5Y
N/A
PE RATIO AVG 10Y
N/A
PE RATIO AVG 15Y
N/A
PE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
25.48
median of 156 covered companies
CURRENT VS SECTOR MEDIAN
-23.74%
vs the sector median at left
Market Cap
$2.27B
PE Ratio
12.72
TTM Avg
11.87
3Y Avg
13.26
5Y Avg
33.57
Market Cap
$2.24B
PE Ratio
N/A
TTM Avg
6.84
3Y Avg
18.15
5Y Avg
20.42
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Liquidia Corporation (LQDA) | $2.37B | 19.43 | N/A | N/A | N/A |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.40B | N/A | N/A | N/A | N/A |
| ADMA Biologics, Inc. (ADMA)vs › | $2.34B | 14.43 | 17.01 | 39.38 | 39.38 |
| Disc Medicine, Inc. (IRON)vs › | $2.41B | N/A | N/A | N/A | N/A |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.32B | N/A | N/A | N/A | N/A |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.31B | N/A | N/A | N/A | N/A |
| Clover Health Investments, Corp. (CLOV)vs › | $2.42B | N/A | N/A | N/A | N/A |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.27B | 12.72 | 11.87 | 13.26 | 33.57 |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.24B | N/A | 6.84 | 18.15 | 20.42 |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.58B | N/A | 76.83 | 76.83 | 76.83 |
At 19.4, P/E is at an extreme level, where the multiple carries little signal — higher than 0% of readings in its 1-year history.
1-year low
20.2
median
444.7
1-year high
654.4
Trailing P/E
19.4
Forward P/E
10.7
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$26.60
Forward EPS (Est.)
$2.49
Forward P/E
10.70
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PE RATIO |
|---|---|
| 2026-10-05 | 20.19 |
| 2026-10-02 | 20.92 |
| 2026-10-01 | 20.44 |
| 2026-09-30 | 22.10 |
| 2026-09-29 | 51.63 |
| 2026-09-28 | 53.81 |
| 2026-09-25 | 49.98 |
| 2026-09-24 | 51.82 |
| 2026-09-23 | 49.30 |
| 2026-09-22 | 50.14 |
| 2026-09-21 | 48.52 |
| 2026-09-18 | 48.85 |
| 2026-09-17 | 49.95 |
| 2026-09-16 | 50.00 |
| 2026-09-15 | 48.00 |
| 2026-09-14 | 47.70 |
| 2026-09-11 | 48.75 |
| 2026-09-10 | 49.56 |
| 2026-09-09 | 50.49 |
| 2026-09-08 | 49.43 |
| 2026-09-04 | 50.15 |
| 2026-09-03 | 50.13 |
| 2026-09-02 | 50.89 |
| 2026-09-01 | 48.87 |
| 2026-08-31 | 49.79 |
| 2026-08-28 | 49.44 |
| 2026-08-27 | 51.08 |
| 2026-08-26 | 52.12 |
| 2026-08-25 | 51.49 |
| 2026-08-24 | 51.33 |
| 2026-08-21 | 50.12 |
| 2026-08-20 | 51.90 |
| 2026-08-19 | 55.02 |
| 2026-08-18 | 54.29 |
| 2026-08-17 | 56.75 |
| 2026-08-14 | 54.37 |
| 2026-08-13 | 52.66 |
| 2026-08-12 | 566.43 |
| 2026-08-11 | 633.00 |
| 2026-08-10 | 654.42 |
| 2026-08-07 | 648.60 |
| 2026-08-06 | 642.85 |
| 2026-08-05 | 640.69 |
| 2026-08-04 | 635.37 |
| 2026-08-03 | 602.80 |
| 2026-07-31 | 604.67 |
| 2026-07-30 | 624.01 |
| 2026-07-29 | 624.16 |
| 2026-07-28 | 624.16 |
| 2026-07-27 | 606.90 |
| 2026-07-24 | 619.84 |
| 2026-07-23 | 640.04 |
| 2026-07-22 | 625.74 |
| 2026-07-21 | 581.52 |
| 2026-07-20 | 554.13 |
| 2026-07-17 | 574.69 |
| 2026-07-16 | 541.12 |
| 2026-07-15 | 558.95 |
| 2026-07-14 | 549.89 |
| 2026-07-13 | 511.93 |
| 2026-07-10 | 560.24 |
| 2026-07-09 | 585.55 |
| 2026-07-08 | 571.32 |
| 2026-07-07 | 583.97 |
| 2026-07-06 | 569.45 |
| 2026-07-02 | 567.43 |
| 2026-07-01 | 570.24 |
| 2026-06-30 | 573.18 |
| 2026-06-29 | 540.04 |
| 2026-06-26 | 561.97 |
| 2026-06-25 | 552.98 |
| 2026-06-24 | 543.06 |
| 2026-06-23 | 532.28 |
| 2026-06-22 | 542.70 |
| 2026-06-18 | 510.93 |
| 2026-06-17 | 493.53 |
| 2026-06-16 | 488.93 |
| 2026-06-15 | 516.18 |
| 2026-06-12 | 512.08 |
| 2026-06-11 | 514.95 |
| 2026-06-10 | 469.09 |
| 2026-06-09 | 460.17 |
| 2026-06-08 | 459.38 |
| 2026-06-05 | 444.64 |
| 2026-06-04 | 449.60 |
| 2026-06-03 | 400.36 |
| 2026-06-02 | 396.19 |
| 2026-06-01 | 422.36 |
| 2026-05-29 | 444.72 |
| 2026-05-28 | 445.94 |
| 2026-05-27 | 445.94 |
| 2026-05-26 | 432.06 |
| 2026-05-22 | 438.39 |
| 2026-05-21 | 445.51 |
| 2026-05-20 | 444.07 |
| 2026-05-19 | 431.20 |
| 2026-05-18 | 409.56 |
| 2026-05-15 | 409.27 |
| 2026-05-14 | 426.31 |
| 2026-05-13 | 414.02 |
| 2026-05-12 | 406.90 |